SIGHT SCIENCES, INC. Operating Cash Flow
SIGHT SCIENCES, INC. (SGHT) reported Operating Cash Flow of -$12.69 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- SIGHT SCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$5.66M.
- SIGHT SCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$7.03M.
- SIGHT SCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.83M.
- SIGHT SCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$8.72M, a 2508.56% decline year-over-year.
- SIGHT SCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$29.69M.
- SIGHT SCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$22.35M.
- SIGHT SCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$47.18M.
- SIGHT SCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$75.97M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$5.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$12.69M 10-Q · filed 2026-08-05 | -$14.52M derived: sum of 3 quarters · filed 2026-08-05 | -$23.24M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$7.03M 10-Q · filed 2026-05-06 | -$8.86M derived: sum of 2 quarters · filed 2026-05-06 | -$17.57M derived: sum of 3 quarters · filed 2026-05-06 | -$25.12M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$10.55M derived: sum of 2 quarters · filed 2026-03-04 | -$18.09M derived: sum of 3 quarters · filed 2026-08-05 | -$29.69M 10-K · filed 2026-03-04 |
| 2025-09-30 | -$8.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$16.26M derived: sum of 2 quarters · filed 2026-08-05 | -$27.87M 10-Q · filed 2025-11-06 | -$31.33M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$7.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$19.15M 10-Q · filed 2026-08-05 | -$22.61M derived: sum of 3 quarters · filed 2026-08-05 | -$22.25M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$11.61M 10-Q · filed 2026-05-06 | -$15.06M derived: sum of 2 quarters · filed 2026-05-06 | -$14.70M derived: sum of 3 quarters · filed 2026-05-06 | -$24.17M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$3.10M derived: sum of 2 quarters · filed 2026-03-04 | -$12.56M derived: sum of 3 quarters · filed 2026-03-04 | -$22.35M 10-K · filed 2026-03-04 |
| 2024-09-30 | $362.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$9.11M derived: sum of 2 quarters · filed 2025-11-06 | -$18.89M 10-Q · filed 2025-11-06 | -$25.38M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$9.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$19.25M 10-Q · filed 2025-08-07 | -$25.74M derived: sum of 3 quarters · filed 2025-08-07 | -$35.57M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$9.79M 10-Q · filed 2025-05-08 | -$16.27M derived: sum of 2 quarters · filed 2025-05-08 | -$26.10M derived: sum of 3 quarters · filed 2025-05-08 | -$39.59M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$6.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$16.31M derived: sum of 2 quarters · filed 2025-03-07 | -$29.80M derived: sum of 3 quarters · filed 2025-03-07 | -$47.18M 10-K · filed 2025-03-07 |
| 2023-09-30 | -$9.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$23.32M derived: sum of 2 quarters · filed 2024-11-07 | -$40.70M 10-Q · filed 2024-11-07 | -$56.20M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$13.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$30.87M 10-Q · filed 2024-08-02 | -$46.37M derived: sum of 3 quarters · filed 2024-08-02 | -$66.57M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | -$17.38M 10-Q · filed 2024-05-06 | -$32.88M derived: sum of 2 quarters · filed 2024-05-06 | -$53.08M derived: sum of 3 quarters · filed 2024-05-06 | -$71.38M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | -$15.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$35.69M derived: sum of 2 quarters · filed 2024-03-13 | -$54.00M derived: sum of 3 quarters · filed 2024-03-13 | -$75.97M 10-K · filed 2024-03-13 |
| 2022-09-30 | -$20.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$38.50M derived: sum of 2 quarters · filed 2023-11-07 | -$60.46M 10-Q · filed 2023-11-07 | -$71.19M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$18.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$40.27M 10-Q · filed 2023-08-07 | -$50.99M derived: sum of 3 quarters · filed 2023-08-07 | -$67.50M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$21.97M 10-Q · filed 2023-05-08 | -$32.69M derived: sum of 2 quarters · filed 2023-05-08 | -$49.20M derived: sum of 3 quarters · filed 2023-05-08 | -$61.64M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | -$10.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$27.23M derived: sum of 2 quarters · filed 2023-03-16 | -$39.67M derived: sum of 3 quarters · filed 2023-03-16 | -$52.54M 10-K · filed 2023-03-16 |
| 2021-09-30 | -$16.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$28.95M derived: sum of 2 quarters · filed 2022-11-10 | -$41.82M 10-Q · filed 2022-11-10 | -$50.37M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$12.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$25.31M 10-Q · filed 2022-08-11 | -$33.86M derived: sum of 3 quarters · filed 2022-08-11 | -$42.47M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$12.87M 10-Q · filed 2022-05-10 | -$21.42M derived: sum of 2 quarters · filed 2022-05-10 | -$30.04M derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | -$8.55M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$17.16M derived: sum of 2 quarters · filed 2022-03-24 | -$32.17M 10-K · filed 2022-03-24 | |
| 2020-09-30 | -$8.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$23.62M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$15.01M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |